Amryt Pharma Holdings Ltd
LSE:AMYT

Watchlist Manager
Amryt Pharma Holdings Ltd Logo
Amryt Pharma Holdings Ltd
LSE:AMYT
Watchlist
Price: 143 GBX -11.73% Market Closed
Market Cap: 457.1m GBX
Have any thoughts about
Amryt Pharma Holdings Ltd?
Write Note

Amryt Pharma Holdings Ltd
Cash from Investing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Amryt Pharma Holdings Ltd
Cash from Investing Activities Peer Comparison

Comparables:
GSK
AZN
VRNA
HIK
DPH

Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Investing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Amryt Pharma Holdings Ltd
LSE:AMYT
Cash from Investing Activities
-$2.4m
CAGR 3-Years
-87%
CAGR 5-Years
-17%
CAGR 10-Years
N/A
GlaxoSmithKline PLC
LSE:GSK
Cash from Investing Activities
ÂŁ398m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-7%
AstraZeneca PLC
LSE:AZN
Cash from Investing Activities
-$7.6B
CAGR 3-Years
-295%
CAGR 5-Years
-379%
CAGR 10-Years
-1%
Verona Pharma PLC
NASDAQ:VRNA
Cash from Investing Activities
-$45k
CAGR 3-Years
74%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Hikma Pharmaceuticals PLC
LSE:HIK
Cash from Investing Activities
-$320m
CAGR 3-Years
-4%
CAGR 5-Years
-27%
CAGR 10-Years
-10%
Dechra Pharmaceuticals PLC
LSE:DPH
Cash from Investing Activities
-ÂŁ426.2m
CAGR 3-Years
-74%
CAGR 5-Years
-12%
CAGR 10-Years
-36%

See Also

What is Amryt Pharma Holdings Ltd's Cash from Investing Activities?
Cash from Investing Activities
-2.4m USD

Based on the financial report for Dec 31, 2020, Amryt Pharma Holdings Ltd's Cash from Investing Activities amounts to -2.4m USD.

What is Amryt Pharma Holdings Ltd's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 5Y
-17%

The average annual Cash from Investing Activities growth rates for Amryt Pharma Holdings Ltd have been -87% over the past three years , -17% over the past five years .

Back to Top